JMP Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $32

JMP Securities analyst Reni Benjamin maintains $Kura Oncology(KURA.US)$ with a buy rating, and maintains the target price at $32.According to TipRanks data, the analyst has a success rate of 0.0% and

moomoo NewsJun 18 00:32 ET · Ratings

BofA Securities Maintains Kura Oncology(KURA.US) With Buy Rating

BofA Securities analyst Jason Zemansky maintains $Kura Oncology(KURA.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 67.9% and a total average return of 31.3% over

moomoo NewsJun 13 09:32 ET · Ratings

Express News | Kura Oncology Inc : BofA Global Research Raises Price Objective to $35 From $33

ReutersJun 13 06:38 ET

Dynavax, Bloomin Brands, and Premier Are the Most Shorted Small-cap Stock in May - Hazeltree Report

Seeking AlphaJun 11 12:40 ET

Kura Oncology(KURA.US) Officer Sells US$57,916.24 in Common Stock

$Kura Oncology(KURA.US)$ Officer Bair Teresa Brophy sold 2,615 shares of common stock on May 20, 2024 at an average price of $22.1477 for a total value of $57,916.24.Source: Announcement What is state

moomoo NewsMay 20 19:09 ET

Investor Enthusiasm Soars for Kura Oncology (NASDAQ:KURA)

TipRanksMay 19 06:15 ET